Should I Buy CYCN Stock in 2026?
Data-driven analysis and honest assessment for Cyclerion Therapeutics Inc
Current Price: $1.35
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
P/E data not available
Slow growth of 2%
Currently unprofitable
Financial health data limited
Negative free cash flow
No recent insider activity
Key Investment Metrics
Current Price
$1.35
P/E Ratio
N/A
Revenue Growth
3.5%
Profit Margin
-0.8%
Market Cap
$0.0B
Dividend Yield
None
How CYCN Compares to Competitors
Understanding how CYCN stacks up against peers helps inform your investment decision.
How CYCN Compares to Peers
Upcoming Events for CYCN
+5 Reasons TO Buy CYCN
1. High gross margins of 93%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy CYCN
1. Company is not profitable
high riskCurrently losing money. May need to raise capital or cut operations.
2. Negative free cash flow
high riskBurning cash creates funding risk and limits shareholder returns.
3. Small-cap volatility risk
high riskMarket cap under $2B means higher volatility and lower liquidity.
Who Should Buy CYCN?
Investment Profile
Risk Level
Very High
Recommended Holding Period
5+ years (turnaround required)
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 4% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in CYCN, compare these Health Care peers:
Pro tip: Compare CYCN directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for CYCN
Frequently Asked Questions
What is CYCN stock price today?
CYCN (Cyclerion Therapeutics Inc) stock is trading at $1.35 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is CYCN stock going up or down today?
CYCN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy CYCN stock now?
The decision to buy CYCN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is CYCN a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for CYCN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is CYCN stock overvalued or undervalued?
Use our DCF valuation calculator to determine if CYCN is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is CYCN's P/E ratio?
P/E ratio data for CYCN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is CYCN's market cap?
CYCN (Cyclerion Therapeutics Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.
What is CYCN's price to book ratio?
CYCN trades at a price-to-book (P/B) ratio of 0.54, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Cyclerion Therapeutics Inc
Full Stock Analysis
Complete CYCN overview with charts and data
Is CYCN Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how CYCN stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Cyclerion Therapeutics Inc
Complete CYCN Analysis
Compare CYCN With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.